Perifoveal Choriocapillaris Flow Deficits Associated With Cerebrospinal Fluid Aβ42/tau in Presymptomatic Alzheimer's Disease.
Date: 2025
PMID: 40434374
90 Results Found
The African Initiative for Bioinformatics Online Training in Neurodegenerative Diseases (AI-BOND): Investing in the next generat
Date: 2024
PMID: 39748840
A charge reversal approach for the sensitive quantification of dicarboxylic acids using Liquid chromatography-tandem mass spectr
Date: 2024
PMID: 39423602
Higher sodium in older individuals or after stroke/reperfusion, but not in migraine or Alzheimer's disease - a study in differen
Date: 2024
PMID: 39284837
Differential Patterns of Gut and Oral Microbiomes in Hispanic Individuals with Cognitive Impairment.
Date: 2024
PMID: 39211240
Disrupted brain functional connectivity as early signature in cognitively healthy individuals with pathological CSF amyloid/tau.
Date: 2024
PMID: 39179782
Associations of Plasma Glutamatergic Metabolites with Alpha Desynchronization during Cognitive Interference and Working Memory T
Date: 2024
PMID: 38891102
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias.
Date: 2023
PMID: 36479795
Alpha desynchronization during Stroop test unmasks cognitively healthy individuals with abnormal CSF Amyloid/Tau.
Date: 2022
PMID: 35066324
Editorial: Lipid Metabolism and Transport in CNS Health and Disease.
Date: 2021
PMID: 34721089
Task switching reveals abnormal brain-heart electrophysiological signatures in cognitively healthy individuals with abnormal CSF
Date: 2021
PMID: 34666107
Plasma Lipolysis and Changes in Plasma and Cerebrospinal Fluid Signaling Lipids Reveal Abnormal Lipid Metabolism in Chronic Migr
Date: 2021
PMID: 34531722
Metabolic Evidence Rather Than Amounts of Red or Processed Meat as a Risk on Korean Colorectal Cancer.
Date: 2021
PMID: 34357356
Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with
Date: 2021
PMID: 33724462
Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer's
Date: 2020
PMID: 33390893
Compromised Behavior and Gamma Power During Working Memory in Cognitively Healthy Individuals With Abnormal CSF Amyloid/Tau.
Date: 2020
PMID: 33192465
Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
Date: 2020
PMID: 32663228
Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies.
Date: 2020
PMID: 32581851
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
Date: 2020
PMID: 32469871
Urine dicarboxylic acids change in pre-symptomatic Alzheimer's disease and reflect loss of energy capacity and hippocampal volum
Date: 2020
PMID: 32298384
Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pr
Date: 2020
PMID: 32116789
Endogenous Na+, K+-ATPase inhibitors and CSF [Na+] contribute to migraine formation.
Date: 2019
PMID: 31173612
Alpha desynchronization during simple working memory unmasks pathological aging in cognitively healthy individuals.
Date: 2019
PMID: 30601822
Alpha desynchronization/synchronization during working memory testing is compromised in acute mild traumatic brain injury (mTBI)
Date: 2018
PMID: 29444081
Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.
Date: 2017
PMID: 28114437
Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.
Date: 2016
PMID: 27532692
Severe Headache or Migraine History Is Inversely Correlated With Dietary Sodium Intake: NHANES 1999-2004: A Response.
Date: 2016
PMID: 27432628
Severe Headache or Migraine History is Inversely Correlated With Dietary Sodium Intake: NHANES 1999-2004.
Date: 2016
PMID: 27016121
ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzh
Date: 2016
PMID: 26873692
Amniotic fluid levels of phospholipase A2 in fetal rats with retinoic acid induced myelomeningocele: the potential "second hit"
Date: 2016
PMID: 26513600
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Date: 2015
PMID: 26844268
Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.
Date: 2015
PMID: 25938590
Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are a
Date: 2014
PMID: 24956173
Altered brainstem auditory evoked potentials in a rat central sensitization model are similar to those in migraine.
Date: 2014
PMID: 24680742
Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control stud
Date: 2013
PMID: 24260210
Phospholipase C activity increases in cerebrospinal fluid from migraineurs in proportion to the number of comorbid conditions: a
Date: 2013
PMID: 23826990
Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease.
Date: 2013
PMID: 23868911
Na,K-ATPase alpha isoforms at the blood-cerebrospinal fluid-trigeminal nerve and blood-retina interfaces in the rat.
Date: 2013
PMID: 23497725
Sodium MRI in a rat migraine model and a NEURON simulation study support a role for sodium in migraine.
Date: 2011
PMID: 21816771
Extracellular sodium modulates the excitability of cultured hippocampal pyramidal cells.
Date: 2011
PMID: 21679932
Cerebrospinal fluid phospholipase C activity increases in migraine.
Date: 2011
PMID: 20937607
Blood serum alpha fetoprotein enhancer binding protein, a tumor suppressor, decreases in chronic HBV hepatitis patients as hepat
Date: 2010
PMID: 20534899
Cerebrospinal fluid sodium rhythms.
Date: 2010
PMID: 20205754
Capillary endothelial Na(+), K(+), ATPase transporter homeostasis and a new theory for migraine pathophysiology.
Date: 2010
PMID: 19845787
Combining lipidomics and proteomics of human cerebrospinal fluids.
Date: 2009
PMID: 19763471
The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal
Date: 2009
PMID: 19735572
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.
Date: 2009
PMID: 19396704
Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects.
Date: 2007
PMID: 17031479
Quantification of free amino acids and dipeptides using isotope dilution liquid chromatography and electrospray ionization tande
Date: 2007
PMID: 17031482
Cerebrospinal fluid sodium increases in migraine.
Date: 2006
PMID: 16866716
Enhanced sequence coverage of proteins in human cerebrospinal fluid using multiple enzymatic digestion and linear ion trap LC-MS
Date: 2006
PMID: 16772279
Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology.
Date: 2006
PMID: 16410653
Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods.
Date: 2006
PMID: 16410651
Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges.
Date: 2006
PMID: 16410649
Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human
Date: 2002
PMID: 12153573
Enhancement of mast cell survival: a novel function of some secretory phospholipase A(2) isotypes.
Date: 2001
PMID: 11591736
Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite bio
Date: 2001
PMID: 11523697
A decrease in remodeling accounts for the accumulation of arachidonic acid in murine mast cells undergoing apoptosis.
Date: 2001
PMID: 11022038
Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in hum
Date: 2000
PMID: 10917903
15-deoxy-Delta(12,14)PGJ(2) induces diverse biological responses via PPARgamma activation in cancer cells.
Date: 2000
PMID: 10936413
Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
Date: 2000
PMID: 10946309
Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells.
Date: 1999
PMID: 10626809
Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells.
Date: 1999
PMID: 10506103
Role of arachidonyl triglycerides within lipid bodies in eicosanoid formation by human polymorphonuclear cells.
Date: 1999
PMID: 10423409
Determination of phospholipase A2s expression in mast cells by reverse-transcriptase polymerase chain reaction.
Date: 1999
PMID: 10343313
Assessment of arachidonic acid distribution into phospholipids of inflammatory cells.
Date: 1999
PMID: 10343312
Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells.
Date: 1999
PMID: 10334191
Mechanisms that account for the selective release of arachidonic acid from intact cells by secretory phospholipase A2.
Date: 1998
PMID: 9748613
Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans.
Date: 1997
PMID: 9237935
Antigen-induced generation of lyso-phospholipids in human airways.
Date: 1996
PMID: 8642333
Control of arachidonate levels within inflammatory cells.
Date: 1996
PMID: 8555241
Metabolism of gammalinolenic acid in human neutrophils.
Date: 1996
PMID: 8609415
Characterization of a secretory phospholipase A2 in human bronchoalveolar lavage fluid.
Date: 1996
PMID: 8792123
Alterations in arachidonic acid metabolism in mouse mast cells induced to undergo maturation in vitro in response to stem cell f
Date: 1996
PMID: 8648030
Relationship between arachidonate--phospholipid remodeling and apoptosis.
Date: 1996
PMID: 8703924
Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators.
Date: 1995
PMID: 7562506
Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.
Date: 1995
PMID: 7544805
Inhibitors of CoA-independent transacylase block the movement of arachidonate into 1-ether-linked phospholipids of human neutrop
Date: 1995
PMID: 7727398
Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells.
Date: 1995
PMID: 7536192
Inhibition of CoA-independent transacylase reduces inflammatory lipid mediators.
Date: 1995
PMID: 7732911
Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate
Date: 1994
PMID: 8053897
Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells.
Date: 1994
PMID: 8189063
The purification and molecular weight determination of rat liver microsomal phospholipid N-methyltransferase.
Date: 1993
PMID: 8132018
Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
Date: 1993
PMID: 8392098
Mobilization of different arachidonate pools and their roles in the generation of leukotrienes and free arachidonic acid during
Date: 1993
PMID: 8419489
Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage.
Date: 1993
PMID: 8380809
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized
Date: 1992
PMID: 1530582
Rapid remodeling of arachidonate from phosphatidylcholine to phosphatidylethanolamine pools during mast cell activation.
Date: 1992
PMID: 1541818
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell.
Date: 1991
PMID: 1892888
Solubilization and purification of lipid methyltransferase.
Date: 1990
PMID: 2379708